Document is current
Any future updates will be listed below
-
Authors
Madsen, Jasmine Melissa
Kjaer, Alexander Krüger
Lønborg, Jacob Thomsen
Køber, Lars
Glinge, Charlotte
Jabbari, Reza
Engstrøm, Thomas
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 31 October 2024
Accepted: 16 December 2024
First Online: 4 January 2025
Declarations
:
: The salary of JM. Madsen was supported by a grant from the Research Foundation of Rigshospitalet (E-22670–08). T. Engstrøm has received speaker fees from Abbott Vascular, Boston Scientific, and Bayer, an advisory board fee from Abbott, Novo Nordisk and partici-pated in Data Safety Monitoring of the INFINITY Trial, unrelated to this topic. J. Lønborg has received an advisory board fee, an unrestricted grant, and speakers fee from Boston Sci-entific and speakers fee from Abbott, unrelated to this topic. All other authors have no con-flicts of interest to disclose. L. Køber has received speaker’s honorarium from Novo Nordisk, Astra-Zeneca, Boehringer and Novartis. All other authors have nothing to declare.
: All civil registration numbers were encrypted which enabled anonymity in all included patients. All register-based studies in an anonymous setup do not require ethical approval in Denmark. The authors are solely responsible for the design and conduct of this study, all analyses, drafting and editing of the paper and its final contents.
